# FDA Warning Letter: Intas Pharmaceuticals Limited
> 2026-04-28 · Center for Drug Evaluation and Research (CDER) · `ec638278931c1905`
## Letter
- **Company:** Intas Pharmaceuticals Limited
- **Posted Date:** 2026-04-28
- **Letter Issue Date:** 2026-03-30
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · MORVS · CC0 1.0*